Literature DB >> 18922876

Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo.

M Zahidunnabi Dewan1, Naofumi Takamatsu, Tomonori Hidaka, Kinta Hatakeyama, Shingo Nakahata, Jun-ichi Fujisawa, Harutaka Katano, Naoki Yamamoto, Kazuhiro Morishita.   

Abstract

Adult T-cell leukemia (ATL) is associated with human T-cell leukemia virus type 1 infection. The tumor suppressor lung cancer 1 (TSLC1) gene was previously identified as a novel cell surface marker for ATL, and this study demonstrated the involvement of TSLC1 expression in tumor growth and organ infiltration of ATL cells. In experiments using NOD/SCID/gamma c(null) mice, both leukemia cell lines and primary ATL cells with high TSLC1 expression caused more tumor formation and aggressive infiltration of various organs of mice. Our results suggest that TSLC1 expression in ATL cells plays an important role in the growth and organ infiltration of ATL cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922876      PMCID: PMC2583669          DOI: 10.1128/JVI.01149-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer.

Authors:  M Kuramochi; H Fukuhara; T Nobukuni; T Kanbe; T Maruyama; H P Ghosh; M Pletcher; M Isomura; M Onizuka; T Kitamura; T Sekiya; R H Reeves; Y Murakami
Journal:  Nat Genet       Date:  2001-04       Impact factor: 38.330

2.  The tumor suppressor protein TSLC1 is involved in cell-cell adhesion.

Authors:  Mari Masuda; Mika Yageta; Hiroshi Fukuhara; Masami Kuramochi; Tomoko Maruyama; Akio Nomoto; Yoshinori Murakami
Journal:  J Biol Chem       Date:  2002-06-05       Impact factor: 5.157

3.  Efficient intervention of growth and infiltration of primary adult T-cell leukemia cells by an HIV protease inhibitor, ritonavir.

Authors:  M Zahidunnabi Dewan; Jun-nosuke Uchihara; Kazuo Terashima; Mitsuo Honda; Tetsutaro Sata; Mamoru Ito; Nobutaka Fujii; Kimiharu Uozumi; Kunihiro Tsukasaki; Masao Tomonaga; Yoko Kubuki; Akihiko Okayama; Masakazu Toi; Naoki Mori; Naoki Yamamoto
Journal:  Blood       Date:  2005-09-20       Impact factor: 22.113

Review 4.  Human T lymphotropic virus type-I and adult T-cell leukemia in Japan.

Authors:  Kazunari Yamaguchi; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

5.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB.

Authors:  M Zahidunnabi Dewan; Kazuo Terashima; Midori Taruishi; Hideki Hasegawa; Mamoru Ito; Yuetsu Tanaka; Naoki Mori; Tetsutaro Sata; Yoshio Koyanagi; Michiyuki Maeda; Yoko Kubuki; Akihiko Okayama; Masahiro Fujii; Naoki Yamamoto
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

9.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  23 in total

1.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

2.  Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.

Authors:  Masaaki Watanabe; Shingo Nakahata; Makoto Hamasaki; Yusuke Saito; Yohei Kawano; Tomonori Hidaka; Kiyoshi Yamashita; Kazumi Umeki; Tomohiko Taki; Masafumi Taniwaki; Akihiko Okayama; Kazuhiro Morishita
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Clinicopathological analysis in PTCL-NOS with CADM1 expression.

Authors:  Takeharu Kato; Hiroaki Miyoshi; Seiichiro Kobayashi; Noriaki Yoshida; Yoshitaka Imaizumi; Masao Seto; Kaoru Uchimaru; Yasushi Miyazaki; Koichi Ohshima
Journal:  Virchows Arch       Date:  2017-09-22       Impact factor: 4.064

4.  CADM1 interacts with Tiam1 and promotes invasive phenotype of human T-cell leukemia virus type I-transformed cells and adult T-cell leukemia cells.

Authors:  Mari Masuda; Tomoko Maruyama; Tsutomu Ohta; Akihiko Ito; Tomayoshi Hayashi; Kunihiko Tsukasaki; Shimeru Kamihira; Shoji Yamaoka; Hiroo Hoshino; Teruhiko Yoshida; Toshiki Watanabe; Eric J Stanbridge; Yoshinori Murakami
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

5.  Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon.

Authors:  M R López-Huertas; S Callejas; D Abia; E Mateos; A Dopazo; J Alcamí; M Coiras
Journal:  Nucleic Acids Res       Date:  2010-02-05       Impact factor: 16.971

6.  Tumor suppressor TSLC1 inhibits growth, proliferation, invasiveness and angiogenesis in nude mice xenografted tumor of Eca109 cells.

Authors:  Qi-Lian Liang; Guo-Qiang Chen; Qiu-Long Liu; Zhou-Yu Li; Xiang-Ning Zhang; Yuan Zhou; Wen-Ting Ou; Bi-Rong Wang; Li-Ren Hu
Journal:  Int J Clin Exp Med       Date:  2014-06-15

7.  Cell adhesion molecule 1: a novel risk factor for venous thrombosis.

Authors:  Sandra J Hasstedt; Irene D Bezemer; Peter W Callas; Carla Y Vossen; Winifred Trotman; Robert P Hebbel; Christine Demers; Frits R Rosendaal; Edwin G Bovill
Journal:  Blood       Date:  2009-07-30       Impact factor: 22.113

8.  CADM1 isoforms differentially regulate human mast cell survival and homotypic adhesion.

Authors:  Elena P Moiseeva; Mark L Leyland; Peter Bradding
Journal:  Cell Mol Life Sci       Date:  2012-03-22       Impact factor: 9.261

9.  CADM1 is expressed as multiple alternatively spliced functional and dysfunctional isoforms in human mast cells.

Authors:  Elena P Moiseeva; Mark L Leyland; Peter Bradding
Journal:  Mol Immunol       Date:  2012-10-11       Impact factor: 4.407

10.  Differential Expression of CADM1 in Gastrointestinal Stromal Tumors of Different Sites and with Different Gene Abnormalities.

Authors:  Jiayin Yuan; Takako Kihara; Neinei Kimura; Yuka Hashikura; Mizuka Ohkouchi; Koji Isozaki; Tsuyoshi Takahashi; Toshirou Nishida; Akihiko Ito; Seiichi Hirota
Journal:  Pathol Oncol Res       Date:  2021-04-19       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.